Want to join the conversation?
In 3Q15, $SYK's all three business segments delivered YoverY sales growth due to strong momentum in the U.S. which represents about 70% of its sales more than offset modest constant currency gains outside the U.S. Trauma & extremities and neurotechnology continued to post double digit growth.
Still in yesterday’s $PZZA shock. I thought everyone had more pizza this football season!!
$TSLA stock downgraded to sell from hold by brokerage firm CFRA Research. However, the firm lifted the price target by $35 to $240.
$LB shares have plummeted after a disappointing quarter.